Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

BMI vs TTEK: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

TTEK Captures Overall Composite Edge (44.7 HOLD vs 49.8 HOLD), While BMI Leads 4–2 on Growth & Valuation Pillars

TTEK Overall Winner 6-Pillar Tally: BMI 4 – 2 TTEK Matrix Metrics: BMI 4 – 6 TTEK

As of Nov 20, 2026, Tetra Tech Inc (TTEK) captures the overall head-to-head institutional edge over Badger Meter, Inc. (BMI) on higher Unified Composite conviction (44.7/100 HOLD vs. 49.8/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, Growth & Scale), while BMI wins 4–2 across the 6-pillar growth and valuation breakdown. BMI trades at $154.27 (30.9x Forward P/E, 18.8% operating margin) versus TTEK at $36.95 (21.6x Forward P/E, 14.0% operating margin).

  • Composite vs. Pillar Nuance: While BMI currently prints a higher short-term Unified Composite Score (49.8/100 HOLD vs. TTEK 44.7/100 HOLD), TTEK captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (14.0% vs. 18.8% operating margin) and revenue trajectory (-0.9% vs. +0.1% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BMI vs TTEK
BMI NYSE
Badger Meter, Inc.
Totalizing Fluid Meters & Counting Devices
$154.27
-0.17% 1D
Market Cap $4.5B
TTM Revenue $881M
Forward P/E 30.9x
Beta / 30D Vol 0.46β · 51% Vol
Unified Composite Score
49.8 / 100 HOLD
Tech 34.0 Fund 47.0 Flow 56.0 Mom 56.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (7.2% over 20 days), RSI 55
RSI-14: 54.7 · SMA20: $155.14 · SMA50: $139.96
TTEK NASDAQ Head-to-Head Winner
Tetra Tech Inc
Services-Engineering Services
$36.95
-0.94% 1D
Market Cap $9.4B
TTM Revenue $4.35B
Forward P/E 21.6x
Beta / 30D Vol 0.25β · 40% Vol
Unified Composite Score
44.7 / 100 HOLD
Tech 20.0 Fund 42.0 Flow 58.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 45.0 · SMA20: $38.79 · SMA50: $36.27

6-Pillar Scorecard Institutional Category Breakdown (BMI 4 – 2 TTEK)

Columns: Metric · BMI · TTEK
1. Valuation Multiples TTEK
Forward P/E 30.9x 21.6x
Trailing P/E 35.7x 22.1x
PEG Ratio 3.68x 2.10x
EV / Revenue 5.1x 2.2x
2. Growth & Scale TTEK
Revenue Growth (YoY) +0.1% -0.9%
Earnings Growth (YoY) +4.2% +5.8%
TTM Revenue (USD) $881M $4.35B
Market Cap $4.5B $9.4B
3. Profitability & Quality BMI
Gross Margin 41.6% 21.7%
Operating Margin 18.8% 14.0%
Net Profit Margin 14.4% 10.1%
Return on Equity (ROE) 18.7% 24.1%
4. Balance Sheet & Cash Flow BMI
Cash Generation (TTM) $142M $663M EBITDA
Cash Flow Margin 16.2% 15.3% EBITDA Mgn
Net Cash / Leverage $22.80 Book/Sh · 18.7% ROE $7.44 Book/Sh · 24.1% ROE
Dividend Yield 1.05% 0.72%
5. Options & Positioning BMI
Options Structure Phase SURGE CONSOLIDATION
Current IV / %ile 40.4% (7th %ile) 34.1% (19th %ile)
Put/Call OI Skew N/A 0.06x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markup DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat BMI
OpEx & R&D Intensity 22.8% of Rev ($201M) 7.7% of Rev ($335M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Scientific & Technical Instruments Operator Engineering & Construction Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BMI (4) vs TTEK (6)
Institutional Metric BMI TTEK Criterion Row Edge
Market Capitalization
Scale
$4.5B $9.4B Larger Scale TTEK
Trailing P/E Ratio
Valuation
35.7x 22.1x Lower Multiple TTEK
Forward P/E Ratio
Valuation
30.9x 21.6x Lower Multiple TTEK
Revenue Growth (YoY)
Growth
+0.1% -0.9% Higher Growth BMI
Operating Margin (TTM)
Profitability
18.8% 14.0% Higher Margin BMI
Net Profit Margin
Profitability
14.4% 10.1% Higher Margin BMI
Return on Equity (ROE)
Capital Efficiency
18.7% 24.1% Higher ROE TTEK
52-Week Range Position
Momentum
56% ($112–$187) 64% ($26–$43) Stronger Trend TTEK
Beta / 30D Volatility
Risk Regime
0.46β · 51% Vol 0.25β · 40% Vol Lower Realized Risk TTEK
Unified Institutional Score
Composite Signal
49.8 / 100 (HOLD) 44.7 / 100 (HOLD) Higher Composite BMI
Trailing 12M Revenue (USD)
Operating Scale
$881M $4.35B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
41.6% 21.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
3.68x PEG · 5.1x EV/Rev 2.10x PEG · 2.2x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$142M ($22.80 Book/Sh · 18.7% ROE) $663M EBITDA ($7.44 Book/Sh · 24.1% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BMI +2.71 pp
BMI: +3.09% · TTEK: +0.38%
3M Horizon BMI +13.36 pp
BMI: +13.6% · TTEK: +0.24%
6M Horizon TTEK +11.04 pp
BMI: +22.59% · TTEK: +33.63%
1Y Horizon TTEK +13.27 pp
BMI: -8.74% · TTEK: +4.53%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period BMI Revenue TTEK Revenue BMI Op. Margin TTEK Op. Margin Margin Leader
FY2018 $430M $2.96B 13.1% 6.4% BMI
FY2019 $420M $3.11B 14.6% 6.1% BMI
FY2020 $430M $2.99B 15.3% 8.1% BMI
FY2021 $510M $3.21B 15.6% 8.7% BMI
FY2022 $570M $3.50B 15.4% 9.7% BMI
FY2023 $700M $4.52B 16.8% 7.9% BMI
FY2024 $830M $5.20B 19.1% 9.6% BMI
FY2025 $920M $5.44B 20.0% 7.5% BMI

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BMI SURGE
12d in phase · OBV NEUTRAL
Current IV 40.4%
IV Percentile 7th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow NEUTRAL
Exact BMI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
TTEK CONSOLIDATION
64d in phase · OBV DISTRIBUTION
Current IV 34.1%
IV Percentile 19th %ile
Put/Call OI Skew 0.06x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact TTEK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BMI Moat Profile Scale & Operating Efficiency Moat
Scientific & Technical Instruments Operator
Competes within the Scientific & Technical Instruments value chain with $4.5B market capitalization and 18.8% operating margin.
OpEx & R&D Reinvestment 22.8% of Rev ($201M)
90D Engineering Disclosures 0 Published
TTEK Moat Profile Scale & Operating Efficiency Moat
Engineering & Construction Operator
Competes within the Engineering & Construction value chain with $9.4B market capitalization and 14.0% operating margin.
OpEx & R&D Reinvestment 7.7% of Rev ($335M)
90D Engineering Disclosures 0 Published

Investor FAQ BMI vs TTEK Key Questions & Quantitative Answers

As of Nov 20, 2026, Tetra Tech Inc (TTEK) captures the overall head-to-head institutional edge over Badger Meter, Inc. (BMI) on higher Unified Composite conviction (44.7/100 HOLD vs. 49.8/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, Growth & Scale), while BMI wins 4–2 across the 6-pillar growth and valuation breakdown. BMI trades at $154.27 (30.9x Forward P/E, 18.8% operating margin) versus TTEK at $36.95 (21.6x Forward P/E, 14.0% operating margin). Composite vs. Pillar Nuance: While BMI currently prints a higher short-term Unified Composite Score (49.8/100 HOLD vs. TTEK 44.7/100 HOLD), TTEK captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (14.0% vs. 18.8% operating margin) and revenue trajectory (-0.9% vs. +0.1% YoY).

TTEK leads the Growth & Scale pillar: BMI posts +0.1% YoY revenue growth and +4.2% YoY earnings growth on $881M TTM revenue (41.6% gross margin, 18.8% operating margin), compared with TTEK at -0.9% YoY revenue growth and +5.8% YoY earnings growth on $4.35B TTM revenue (21.7% gross margin, 14.0% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), BMI cumulative revenue shifted +114.0% while TTEK shifted +83.8%. In operating R&D and SG&A reinvestment, BMI deploys 22.8% of Rev ($201M) (0 90-day corporate R&D disclosures) versus 7.7% of Rev ($335M) (0 disclosures) for TTEK.

TTEK screens cheaper on headline valuation multiples. BMI trades at 30.9x Forward P/E, 35.7x Trailing P/E, 3.68x PEG, and 5.1x EV/Revenue (16.2% FCF margin), whereas TTEK trades at 21.6x Forward P/E, 22.1x Trailing P/E, 2.10x PEG, and 2.2x EV/Revenue (15.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BMI (18.7% ROE) versus TTEK (24.1% ROE) capital efficiency.

In options market volatility and institutional positioning, BMI carries 40.4% implied volatility (7th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (0.46β · 51% Vol realized risk). By comparison, TTEK carries 34.1% implied volatility (19th %ile, Compressed (<25th %ile)), a 0.06x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.25β · 40% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.